HW
DXCM icon

Hancock Whitney’s DexCom DXCM Stock Holding History

Hancock Whitney’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,312
Closed -$423K – 645
2024
Q3 		$423K Sell
6,312
-103,479
-94% -$8.5M 0.01% 475
2024
Q2 		$12.4M Buy
109,791
+785
+0.7% +$99.2K 0.42% 57
2024
Q1 		$15.1M Buy
109,006
+7,679
+8% +$965K 0.52% 47
2023
Q4 		$12.6M Buy
+101,327
New +$10.4M 0.47% 46

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Hancock Whitney's DXCM Position: Q4 2024 in Review

Hancock Whitney sold out of DexCom (DXCM) in Q4 2024, closing a stake of 6,312 shares — an estimated $423K sold.

Hancock Whitney first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $15.1M in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Hancock Whitney reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Hancock Whitney sold 6,312 DexCom shares in Q4 2024, an estimated $423K.
  • Hancock Whitney first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
  • Hancock Whitney's DexCom position peaked at $15.1M in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Hancock Whitney's 13F filing for Q4 2024, filed 14 Feb 2025.